tirzepatide and depression GLP-1s linked to lower rates of anxiety than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Tirzepatide and Depression Risk |

Arthritis Rheum (2000) 43(11):250112

However, you must consult with your doctor

When patients lose more than 10% of their body weight within three to six months, regardless of the pharmaceutical agent used, the risk of telogen effluvium increases substantially

Safety & Side Effects Transparent information about Retatrutide Most Common Side Effects Mild Nausea (usually during weeks 13) Mild Temporary appetite changes Mild Constipation or diarrhea Mild Mild injection site irritation Most side effects decrease significantly by week 4 as your body adapts Managing Side Effects Start with low dose for tolerance Eat smaller, frequent meals Stay well hydrated Regular follow-ups with doctor Dose adjusted if needed Our medical team provides 24/7 support during your journey Why Medical Supervision Matters Retatrutide requires professional medical oversight to ensure safety and maximize results

Its ability to reduce food intake by enhancing satiety further supports individuals in their weight management efforts, a common challenge among those with type 2 diabetes

However, these challenges are not unique to this domain and mirror those faced by other peptide systems prior to successful translation